Response Genetics Regains Compliance with NASDAQ Listing Standards
Response Genetics has added a news release to its Investor Relations website.
Title: Response Genetics Regains Compliance with NASDAQ Listing Standards
Date(s): 8-Oct-2012 8:01 AM
For a complete listing of our news releases, please click here
LOS ANGELES , Oct. 8, 2012 /PRNewswire/ -- Response Genetics, Inc. (Nasdaq: RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, announced today that on October 5, 2012 , the Company was notified that it has regained compliance with the NASDAQ Capital Market and its minimum market value of listed securities requirement. The Company regained compliance with NASDAQ Marketplace Rule 5550(b)(2) and was notified by NASDAQ that the delisting matter is now closed.